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(Universidad Nacional de La Plata, CIC-PBA, CONICET) and Divisio ́n Química Analítica, Facultad de 
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Abstract 
Polysaccharide-based chiral stationary phases have been recognized as one of the most powerful ones for 
high performance liquid chromatography (HPLC) separations of chiral compounds in analytical and also in 
preparative scale. 
Immobilized polysaccharide-based chiral stationary phases constitute a remarkable achievement due to 
their stable nature on working with standard or common solvents and also with those prohibited for using 
with coated phases.   
This review is mainly focused on the i. applications of these chiral stationary phases in numerous fields of 
HPLC separations; ii. comparative aspects between immobilized vs. coated polysaccharide-derived 
phases, and iii. revision of several theoretical studies such as enantiorecognition mechanism, mobile phase 
composition and column temperature effects. 
 
Keywords: Chiral compounds; Chiral recognition mechanisms; Enantioseparations; High-performance 
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1 Introduction 
 
Stereospecific recognition of chiral molecules and enantiomer discrimination are fundamental phenomena 
in life sciences. The chiral nature of living systems has evident implications on biologically active 
compounds interacting with them, biological systems are sensitive to stereochemistry and different 
responses can be observed when comparing the activities of an enantiomeric pair. Therefore 
stereochemistry has impact in chemical fields that are dealing with bioactive xenobiotic compounds, such 
as drugs, agrochemicals, food additives, fragrances, pollutants, etc. [1–3]. To deal stereoselectivity issues 
in such research, enantioselective liquid chromatography emerged as the method of choice, for both 
analytical and preparative purposes [4,5]. The direct approach using, a chiral stationary phase (CSP mode) 
is nowadays the method of choice for its relative simplicity. This mode employs chiral adsorbents, in most 
cases spherical porous silica supports functionalized with a chiral selector that is covalently linked or 
physically adsorbed.  
Among a large number of CSPs developed the polysaccharides and its derivatives are highly used as chiral 
selectors for HPLC. It is because of their high chiral recognition ability. Polysaccharides are polymers with 
glucose units linked via β(1→4) (cellulose) or α(1→4) (amylose) linkages. Native amylose and cellulose 
are easily converted to a variety of derivatives with higher enantiorecognition ability [6]. Nowadays, 
amylose and cellulose derivatives synthetized by different workers are tribenzoate, tris-(4-methylbenzoate), 
triphenylcarbamate, tris-(3,5-dimethylphenylcarbamate), tris-[(R)-1-phenylethylcarbamate], tris-[(S)-1-
methylphenylcarbamate], tris-(3,5-dichlorophenylcarbamate), etc. These derivatives were firstly coated by 
simple physically adsorption of chiral selectors on macroporous silica gel supports [7,8]. Therefore, they 
can be used only with a limited range of solvents as mobile phases. Then only low-polarity solvents, such 
as mixtures of alkanes (n-pentane, n-hexane, n-heptane, etc.) and alcohols (methanol, ethanol, 2-propanol, 
etc.), or sometimes, acetonitrile can be used for chiral separations under normal phase mode. 
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Unfortunately, commonly used organic solvents, prohibited with these CSPs may be useful to resolve some 
racemates, are used as sample diluents and are also required for the determination of the chiral recognition 
mechanisms using NMR and other spectroscopic techniques [6,9]. Besides, some stereospecific reactions 
are possible only in these solvents and, hence, its progress monitoring is not possible using coated CSPs. 
Therefore, versatility in the solvent selection is highly desired. 
These coated CSPs drawbacks can be solved by preparing immobilized phases [10,11]. Presently, many 
columns, having polysaccharides immobilized on silica gel, are commercially available (Table 1). Several 
immobilization methods to covalently fix the polysaccharide derivatives on silica gel were carried out [10–
16], they include: linkage with (1) diisocyanates, (2) at the reactive terminal, (3) radical polymerization of 
vinyl groups, (4) photo irradiation, (5) click reaction and (6) polycondensation of the alkoxysilyl groups 
[14,17–31]. The high chiral recognition ability is usually due to the regular helical structure of them. 
Therefore, it is well known that on the coated-type CSPs, particularly those derived from cellulose benzoate 
derivatives, the coating conditions on silica gel significantly influence their chiral recognition ability 
[7,8,12,14]. 
Supercritical fluid chromatography (SFC) extend the use of the same polysaccharide CSPs as those for 
HPLC, providing a complementary choice of the GC and HPLC methods. Fig. 1 shows the distribution of 
enantiomeric excess (ee) determination methods, CSPs for chiral HPLC and type of polysaccharide-based 
CSPs reported in the Angewandte Chemie International Edition in 2012. In that year, the journal published 
about 2,100 communication papers and at least 199 of them reported ee determinations. As well as the 
methods in Fig. 1, HPLC and SFC analyses were predominantly peformed with the cellulose-based CSPs, 
Chiralcel OD and OJ, and the amylose-based CSPs, Chiralpak AD and AS. The chemical name of these 
CSPs are shown in Table 1. Some columns include several brand names, such as CellCoat (Kromasil), 
RegisCell (Regis), Eurocel 01 (Knauer), Lux Cellulose-1 (Phenomenex), Sepapak-1 (Sepaserve) and Chiral 
Cellulose-C (YMC), Astec (Sigma-Aldrich), Reprosil Chiral (Dr. Maisch GmbH), besides Chiralcel and 
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Chiralpak (Daicel), respectively. Chiralpak IA and Chiralpak IB, were first time commercialized in 2004. The 
highly successful Chiralpak IC CSP was introduced in 2008 [32], and by 2016, the alphabetic sequence 
had expanded to “IG”. 
The present review highlights recent developments on immobilized polysaccharide-based chiral stationary 
phases for liquid phase separation techniques. Emphasizing in HPLC applications dating between 2013 
and 2017. Topics such as chiral recognition ability of coated vs. immobilized CSPs, chiral recognition 
mechanisms, influence of column temperature and mobile phase composition are extensively discussed. 
Finally, this review tries to give current weak points or shortcomings that could be overcome with future 
developments in order to wider the applications of these promising CSPs.  
 
2 Comparison between coated-type and immobilized-type CSPs 
 
Chiral recognition ability of the immobilized-type CSPs can be different from the coated ones, and often is 
slightly lower. This is because the formation of a regular structure of the polysaccharide chains becomes 
difficult by the incorporation of different side groups necessary for the immobilization.  
Okamoto et al. described in 1987 the first preparation of polysaccharide-based CSPs with 3,5-dichloro and 
3,5-dimethylphenylcarbamate bonded covalently to γ-aminopropylsilica gelmatrix [24]. The resulting CSPs 
were tested with (n-hexane/2-propanol) in order to compare the results with coated CSPs. The stability of 
the 3,5-dichlorophenylaminocarbonyl-derived CSP was higher than the correspondingly coated CSP. 
However, a certain decrease in the enantioselectivity values was observed. A method modification 
involving a regioselective fixation was published for the same research group in 1994 [23]. The 
chromatographic behavior of the obtained CSPs, was compared to the coated CSPs and again a reduction 
in the enantioselectivity was observed. The results obtained for analogous selectors fixed by different 
positions were also compared. Interesting results were obtained when a small amount of chloroform was 
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used in the mobile phase. Some changes in the chiral discrimination ability of the chiral selectors were 
observed. Certain analytes, that were not resolved when the classical mobile phases were used, could be 
separated using mobile phases containing 5% of chloroform. This effect was attributed to a change in the 
conformation of the chiral selector in this solvent. 
Andersson et al. compared the recognition abilities of the immobilized-type CSPs, Chiralpak IA and 
Chiralpak IB, with the corresponding coated-type, Chiralpak AD and Chiralcel OD, respectively [33], for 48 
racemic compounds, and confirmed that coated-type CSPs often exhibit better recognitions. Coated CSPs, 
however, are not capable of resolving certain drugs and pharmaceuticals, especially in reaction mixtures 
when “prohibited solvents” are essential.  
Zhang et al. [34] compared the chiral separation of bupivacaine under identical chromatographic conditions 
acetonitrile/diethylamine (100:0.1, v/v) on Chiralpak AD (coated) and Chiralpak IA (immobilized), better 
resolution was reported on the latter column. Chen et al. [35], compared the chiral recognition of 
immobilized CSPs and reported that chemically bonded CSPs greatly extend the choice of solvents and 
better resolution of several test enantiomers was observed on the immobilized CSPs with the addition of 
tetrahydrofuran and chloroform to the mobile phase. Aboul-Enein et al. [36,37] compared the chiral 
recognition capabilities of the Chiralpak IA column with those of Chiralpak AD for a variety of racemates 
and noted a complementary working nature of these two columns. Moreover, the reversal of the enantiomer 
elution order between coated and covalently immobilized versions of cellulose- and amylose-based (3,5-
dimethylphenylcarbamates) has been reported [16]. Although the chemical composition of the stationary 
phase in the immobilized and coated columns is similar, the chiral recognition in both columns is not the 
same. Indeed, the immobilization of the chiral selector on silica did affect its chiral recognition ability 
showing different (often lower) resolving ability than the coated in the same experimental conditions. This is 
probably due to the change in the polymer configuration and/or supramolecular structure due to the 
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immobilization on the support, different conformations or rigidity of coated and covalently immobilized 
polysaccharide derivatives can be the reason of such a discrepancy in their chiral recognition. 
Kalíková et al. [38] compared two commercially available polysaccharide-based CSPs containing amylose 
tris-(3,5-dimethylphenylcarbamate) chiral selector, coated and immobilized on silica support, under different 
separation conditions. The immobilized CSP, Chiralpak IA, and coated CSP, Chiralpak AD-RH, had 
comparable enantiorecognition potential for acidic analytes in the RP-HPLC mode. Chiralpak AD-RH 
seemed to be a better choice for the separation of basic analytes, despite Chiralpak IA exhibited higher 
retention for most of these analytes. 
Adhikari et al. separated aliphatic amines including amino alcohols by NP-HPLC using six covalently 
bonded and four coated CSPs based on amylose and cellulose. Chiralpak IE showed the best enantiomer 
separation for most analytes among the covalently bonded CSPs, while Chiralpak AD‐H and Amylose‐1 
generally showed higher enantiomer separation among the coated type CSPs [39]. Cirilli et al. compared a 
coated Chiralpak AD column with the new commercial immobilized-type amylose tris-(3-chloro-5-
methylphenylcarbamate) Chiralpak IG for the determination of ricobendazole. Using the IG CSP under 
polar organic mode (100% MeOH or 100% EtOH), retention factors were about two-fold higher and the 
enantioseparation was lower than that obtained with the Chiralpak AD CSP even though the α-values 
remained fairly high (α>2), pure methanol gave the best enantioselectivity conditions [40]. 
Ferretti et al. [41] developed a simple HPLC method for separating triclabendazole sulfoxide (TCBZ-SO) 
enantiomers. First, the authors employed commercial columns with broad chiral discrimination ability, such 
as Chiralpak IA, IB and IC then no resolution or modest enantioselectivity values were obtained. 
Surprisingly, when they used a Chiralpak AS-H (amylose tris-[(S)-α-methylphenylcarbamate] coated and 
also the Chiralpak IF complete resolution for TCBZ-SO was achieved. At 25 ºC, with n-
hexane/ethanol/trifluoroacetic acid (70:30:0.1, v/v/v) as mobile phase, Chiralpak AS-H gave an 
enantioselectivity value (α=1.87) higher than Chiralpak IF (α=1.26). However, since the immobilization of 
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the chiral selector, it was possible to explore new selectivity profiles using mobile phases containing ethyl 
acetate, dichloromethane, tetrahydrofuran and acetone [42,43]. With the “non-standard” elution mixture n-
hexane/ethanol/ethyl acetate/trifluoroacetic acid (70:1:30:0.1, v/v/v/v), the TCBZ-SO enantiomers were well 
resolved with enantioseparation and resolution factor values of 1.45 and 5.17, respectively [41]. Gallinella 
et al. reported the analysis of oxaliplatin (platinum(II) anticancer drug) carried out with a Chiralpak IC 
column under optimized chromatographic conditions (column temperature= 40 ºC, flow rate= 1.0 mL min−1, 
mobile phase= acetonitrile/water (100:5, v/v)). Oxaliplatin enantiomers were better resolved in a shorter 
analysis time (8 min) than required in the application of the method established by regulatory agencies (21 
min) using Chiralcel OC column. The developed method demonstrates the applicability of hydrophilic 
interaction liquid chromatography (HILIC) mode for the enantioseparation in a better, simpler and faster 
way respect to the method reported in the current Pharmacopoeias. And also has the potential to provide 
reliable and effective LC–MS analyses of pharmaceutical formulation containing oxaliplatin [44]. 
 
3 Applications 
 
Applications of immobilized polysaccharides CSPs (Chiralpak columns) are summarized in the Tables 2-4. 
It is well known that a single CSP cannot be universally used for chiral resolution of all racemic compounds. 
Tables 2-4 provides CSPs trade names and their most relevant applications published between 2013-
2017. Some interesting applications are discussed here. Various pharmaceutical, biological and veterinary 
compounds (Table 2), pesticides (Table 3) and organic, polyaromatic, natural and synthetic compounds 
(Table 4) have been resolved on immobilized polysaccharides CSPs at both analytical and 
semi/preparative scales [40,41,45–51]. In all these cases, the authors used reversed or normal phase 
modes. Other solvents, for example, chloroform and 2-propanol mixture with a Chiralpak IA, were used for              
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analytical and semipreparative separation of chiral 9,9-Spirobifluorenes derivatives obtaining Rs>>1.5 and 
enantioselectivity factor about 4.3 [47].   
Many papers are aimed to the determination of herbicides [103,104,108,110], insecticides 
[48,100,97,107,105], fungicides [102,109,106,101,99] or antiviral drugs [98] from many different chemical 
families, including aryloxyphenoxy propionic acids, pyridines, oxadiazines, phenylpyrazoles, acylalanines, 
pyrethroids, triazoles, α-aminophosphonates, sulfoxides, etc. have been determinated in environmental or 
food samples (soil, natural waters, fruits, vegetables, etc.). Pharmaceutical compounds recognized as 
potential anti-carcinogen agents [44,45,56,92,64], α- and β- adrenergic receptor blockers [51,92,59,65–
68,60], nonsteroidal anti-inflammatory drugs [38], antihistamines [92,74], proton pump inhibitors 
[50,94,73,79,81,88,96,76], retroviral drugs [55,84], antihyperglycemic drugs [83], antihelminthic agents 
[40,57], anti-hypertensive drugs [41,53,85], L-type calcium channel [72,89], broad-spectrum antimicrobials 
[95,70], nootropic drugs [90,91], anticoagulant drugs [69], etc. have also been determined, especially in 
commercial products or biological samples (pharmaceutical formulations, human urine, human or animal 
blood, human plasma, animal serum, etc.). Another heterogeneous group of analytes, including connectors 
for building metal-organic frameworks [116,117,124], intermediates for the synthesis of pharmaceuticals 
[111], natural and synthetic compounds [39,113,121,120], biological compounds [82,112,58,71,78,86,61–
63,77,75], natural alkaloids [121], biomolecules [115,54], organometallic compounds [119] and chiral 
metabolites [103,108,100,97,102,59,63,52] has been enantioseparated with these immobilized 
polysaccharides CSPs (see Table 2-4). Fig. 2 shows the number of publications reported in the last five 
years for chiral separations obtained with all available Chiralpak columns under HPLC and also SCF 
methods. The noticeable difference in the number of HPLC and SCF papers published for Chiralpak IF and 
IG must be undoubtedly due that these columns are the newest in the series, and they have incipient use in 
HPLC methodologies. It is expected that SFC applications increase over time. 
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4 Theoretical studies using polysaccharide CSPs 
4.1. Chiral recognition mechanisms 
 
Selector-selectand complexes are thought to be primarily mediated via hydrogen bonds as well as π-π 
interactions and van der Waals forces [125–127]. Especially the carbamate linkage allows some flexibility 
of the aromatic rings for maximizing π-π interactions and van der Waals forces upon binding with the 
solute. The mobile phase composition may modulate the recognition process. Thus, reversal of the 
enantiomer elution order depending on the composition of the mobile phase has been observed [16]. 
Furthermore, based on a systematic study for the enantioseparation of polyhalogenated 4,4’-bipyridines on 
polysaccharide-based chiral stationary phases including structure-separation relationships as well as 
computational evaluation of the geometries and electron distribution of selectors and selectands. Peluso 
and coworkers pointed out a contribution of halogen bonding interaction for analyte stereorecognition by 
cellulose tris-(3,5-dimethylphenylcarbamate) [116,117]. Studies on the elucidation of the chiral recognition 
mechanism of polysaccharide chiral selectors have been performed by various techniques including 
chromatography, NMR spectroscopy, vibrational circular dichroism spectroscopy or molecular modeling as 
summarized earlier in [1,125–128], while applications to chiral separations as well as studies on the 
separation ability of the selectors can be found in [12–14,16,124,129,130]. 
Hydrogen bonding and π-π interactions were the major factors for the HPLC separation of the four 
stereoisomers of 5-bromo-3-ethyl-3-(4-nitrophenyl)piperidine-2,6-dione on amylose tris-(3,5-
dimethylphenylcarbamate) as derived from molecular docking [56]. Based on modeling results and stereo-
interactions of all the stereoisomers (SS, RR, RS, SR) at supramolecular level with the CSP constituted by 
attractive electrostatic forces among amide groups and two carboxylic groups of stereoisomers and amino, 
amide, hydroxyl and oxide groups of the chiral selector, π–π interactions and hydrogen bonding, the 
authors could explain the elution order for the stereoisomers.  
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The importance of π-π interactions in the chiral recognition process was also discussed for the separation 
of the enantiomers of a pyrrolo[2, 3- c] pyridine drug by SFC [131]. While both enantiomers formed 
hydrogen bonds with the selector amylose tris-(3,5-dimethylphenylcarbamate), only the stronger retained 
(R)-enantiomer established π-π interactions between the pyrrolo[2, 3-c] pyridine moiety and 3,5-
dimethylphenylcarbamate substituents. Docking studies revealed that the complex with the strongly 
retained (S)-enantiomer was stabilized by two π-π interactions of both phenyl rings with 4-methylbenzoate 
substituents of two separate glucose units. The thioamide group formed a hydrogen bond with two oxygen 
atoms of a glucose residue. In contrast, the weaker retained (R)-enantiomer displayed only one π-π 
interaction between the phenyl ring in position 3 and a 4-methylbenzoate substituent as well as one 
hydrogen bond between the thioamide group and a glucose residue. Further enantioseparation studies 
supported by molecular modeling include the enantioseparations of pheniramine, oxybutynin, cetirizine and 
brinzolamide by amylose tris-(3,5-dimethylphenylcarbamate) [132] and also the optical isomers of 
atracurium besylate on cellulose tris-(3,5-dimethylphenylcarbamate) [133]. 
Differences in the formation of hydrogen bonds between the enantiomers of propranolol and cellulose tris-
(3,5-dimethylphenylcarbamate) derived from molecular modeling were used to explain the elution order 
observed in HPLC [66]. The less retained (S)-enantiomer formed a hydrogen bond between the hydroxy 
group of the selectand and the carbamate carbonyl group of the selector while the stronger retained (R)-
enantiomer formed hydrogen bonds with the carbohydrate backbone due to deeper insertion into the chiral 
cavities. π-π Interactions were not considered in this study although they appear very likely based on the 
structures of selector and selectand. 
Quantum chemical calculations of a set of chiral pyrrolidin-2-one derivatives were used to predict structure-
enantioselective retention relationships for amylose tris-(3,5-dimethylphenylcarbamate) as chiral stationary 
phase in the normal phase mode [134]. Although direct solute-selector interactions were not modeled, the 
polar surface area of the solutes as well as a significant role of charge-transfer interactions between the 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
stationary phase and the analyte enantiomers were derived from the calculations, which allowed the 
prediction of the enantioseparation of related structures. 
Several works deal with the effect of the mobile phase composition and the analyte chemical structure on 
the enantioseparation of various racemates. For example, the effect of acidic and basic additives to 2-
propanol and acetonitrile based mobile phases on the enantiomer elution order of chiral β-blockers and 
other basic drugs on commercial polysaccharide chiral columns has been reported [135,136]. The influence 
of the 2,2’-alkyl chains of atropisomeric 1,1’-bibenzimidazole derivatives on an amylose tris-(3,5-
dimethylphenylcarbamate) stationary phase was studied and it was noted that the chain length affected 
binding strength (accounted for analysis time) as well as enantiomer elution order [122]. The effect of 
halogen substitution in a large variety of structurally diverse analytes has also been summarized recently 
[124]. Ramisetti et al. [95] studied the mechanism of separation between a Chiralpak IE column and R-
Besinfloxacin. A large number of interactions between selectand enantiomers and chiral selector can be 
envisaged including dipole–dipole, hydrogen bonding and π–π interactions depending on the experimental 
conditions. The probable mechanism for chiral recognition is predominantly ionic, making it either an 
essential acid or an essential base to be added as mobile phase additive. In this work, a good selectivity 
was achieved by the addition of both acidic trifluoroacetic acid, and basic diethylamine. 
 
4.2. Effect of mobile phase composition 
 
Polysaccharide-type CSPs are most frequently used with organic eluents, however, enantiomer resolution 
by aqueous eluent has largely been used [43,137] too. The choice of RP-mode was often related to analyte 
scarce retentivity, low sample solubility of polar species and lack of enantioselectivity in organic eluents. In 
the last decades, an additional reason to prefer RP methods has been their suitability for LC–MS 
applications [43]. RP chromatography is often complementary to normal mode. 
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If sample components are soluble in aqueous medium and an HPLC separation on polysaccharide-derived 
column will be tested, there are two possibilities: 
(a) Developing a method in polar organic mode. 
(b) Developing a method in reversed-phase conditions. 
For an efficient screening in the polar organic mode on immobilized CSPs, the choice of the solvents often 
includes: 100% acetonitrile (ACN), 100% methanol (MeOH) and/or 100% ethanol (EtOH) (or their 
mixtures). 
This preliminary screening allows to identify potential enantiorecognition with these columns. If this strategy 
is not successful it would be necessary switching to the RP-mode. The first choice of modifier to be 
combined with water is ACN. MeOH can also be useful and, THF seems to be less versatile. 
The presence of water has often an unpredictable impact on the enantiorecognition ability. Water promotes 
a strong solvation effect on the polymeric chiral selector and a substantial weakening of several types of 
interactions, such as the hydrogen bonding, involved in the chiral recognition mechanism. Despite of the 
exhaustive number of studies on the chiral discrimination ability, there is a lacking of information concerning 
the retention behavior of polysaccharide-type CSPs under aqueous-organic conditions. Okamoto and Kaida 
[138] and Kummer and Werner [139] have pointed out that only at high water concentrations the adsorption 
mechanism on polysaccharide derivatives is controlled by hydrophobic interactions. At low water 
concentrations an alternative retention behavior typical of the hydrophilic interaction liquid chromatography 
(HILIC) could be observed. Chankvetadze et al. have related the HILIC behavior to a competition between 
water and analyte for hydrogen binding sites of the polymeric selector [16,140].  
Materazzo et al. [57] separated albendazole and fenbendazole sulfoxides (ABZ-SO and FBZ-SO, 
respectively) using Chiralpak ID and Chiralpak IF colums with mixtures of acetonitrile/water (100:180 and 
100:80, v/v, respectively) as mobile phases (Fig. 3a). Good enantioresolution of FBZ-SO was performed 
using analogue CSP/mobile phase combinations (Fig. 3b). The authors hypothesized that the HILIC and 
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RPLC retention behaviors of the immobilized-type CSPs depend on strong binding sites located outside the 
chemical portions involved in the immobilization of the selector. 
Mobile phase additives are routinely used with the main purpose of improving peak shape and efficiency of 
basic/acidic compounds by minimizing peak tailing and/or broadening. The additives are usually used at 
very low proportion (0.05–0.5%, v/v) and include mainly diethylamine (DEA), triethylamine (TEA), 
isopropylamine (iPA), 2-aminoethanol (AE), ethylenediamine (EDA) or trifluoroacetic acid (TFA), acetic acid 
(AA) and formic acid (FA). Among the basic additives, DEA is the most commonly used and has proved to 
be effective for screening and method development of many basic compounds 
[40,50,51,67,68,60,74,73,55,84,95,111,58,78,62,75,122,87,93,80] (see Tables 2-4). As a general rule, 
basic additives are employed for enantiomer separation of basic compounds, while acidic additives are 
essential for acidic ones. Basic additives in the mobile phase for elution of acidic compounds generally lead 
to no elution [129,141] or very long retention times with peaks in broad hump accompanied by total 
collapse of separation. The usefulness of acidic additives, nevertheless, can sometimes be extended 
beyond the category of acidic compounds. Several studies carried out on certain coated polysaccharide-
based CSPs showed significant effects of acidic additive on basic compounds [141–144]. This 
phenomenon was also observed with the immobilized polysaccharide-based columns, most notably on 
CHIRALPAK IB [129]. For molecules with a certain amphoteric nature, combinations of TEA and TFA can 
also be used in order to improve peak shapes (ion-pairing strategy) [43,73,95]. 
Several studies carried out on certain polysaccharide-based CSPs of immobilized type showed significant 
effects of acidic additive (or acidic with basic mixture additive) mainly on basic compounds 
[41,103,104,108,101,73,53,95,90,91,58,86,63,115,52] (see Tables 2-4). 
For β-blockers enantiomer resolution on Chiralpak IB, both DEA (basic) and TFA (acidic) were added to a 
n-hexane/ethanol (80:20, v/v) mobile phase. A change as low as 0.1% for the mobile phase additive 
produced a notable shift on enantioselectivity [129]. 
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4.3. Effect of temperature on retention and enantioselectivity 
  
Several studies using different CSPs [40,53,145–150] demonstrated that the column temperature should be 
optimized in enantioselective HPLC separations.  
Generally, solute transfer from the mobile to the stationary phase is an exothermic process, and 
consequently Tthe retention factor k often decreases with increasing temperature. 
The retention mechanism is widely explained as a mixed mechanism involving solute–solvent, solute–
sorbent, and solvent–sorbent interactions. The detailed thermodynamic study of these complex retention 
behaviors requires van’t Hoff analysis over a sufficiently wide range of modifier concentrations and the 
development of a thermodynamic retention model. The retention behavior of solutes can be described 
reasonably well using a combination of thermodynamic analysis and a retention model, as was previously 
implemented for solutes with distinct functional groups on Chiralpak IA [151] and Chiralpak IE [150] 
sorbents. 
Cirilli et al. [40] studied the temperature impact on retention, enantioselectivity and resolution of 
ricobendazole. The authors used a Chiralpak IG column and its temperature was changed in the 25–45 ºC 
range at intervals of 5 ºC, using methanol as mobile phase. In all cases, retention decreased with 
increasing temperature. Furthermore, the ln k terms were linearly related (r2 > 0.990) to the inverse of the 
temperature. In contrast, the influence of temperature on enantioselectivity was modest and the ln α values 
did not follow a linear trend as the temperature increased. It is interesting to note that although the 
enantioselectivity changed slightly with temperature, the maximum resolution value 10.90 was at 45 ºC. 
The calculated (Hº) and (Sº) values were positive for IG CSPs (0.43 kcal mol−1 and 3.00 kcal mol−1) 
indicated that the chiral resolution of RBZ on the IG was entropically driven (i.e. |(Hº)| < |T(Sº)|). 
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Recently, Ferretti et al. studied the temperature effect on the enantioresolution parameters of the 
halogenated sulfanyl-benzimidazole derivative triclabendazole using a Chiralpak IF column. The ln k terms 
were linearly related to the inverse of the absolute temperature (r2 > 0.9850). Retention increased with 
temperature only for the IF CSP/n-hexane/EtOH/ethyl acetate/trifluoroacetic acid (70:1:30:0.1, v/v/v/v) 
condition. In most cases, the enantioselectivity and resolution remained almost unchanged or decreased 
when the column temperature increased from 25 to 40 ºC [41]. 
On the other hand, Cirilli’s group developed a direct HPLC method for the separation of Bicalutamide (BCT) 
enantiomers by using a Chiralpak IA column. Enantioselective conditions were achieved using standard 
normal phase mixtures of n-hexane-alcohol (ethanol or 2-propanol) and a “non-standard” mobile phase 
containing ethyl acetate. For the first eluent n-hexane/ethanol (70:30, v/v) the effect of column temperature 
on enantioselectivity and retention was unidirectional. The van’t Hoff plots followed a classical linear pattern 
and the retention factors of both BCT enantiomers as well as the enantioselectivity decreased as the 
column temperature increased. The BCT van’t Hoff plots are markedly different when n-hexane/ethyl 
acetate/ethanol (100:30:5, v/v/v) is used as eluent. The ln α vs. 1/T plot was non-linear and the resolution 
factor reached a maximum value at 40 °C (Rs= 11.08). It is worthwhile noting that this resolution value, is 
slightly higher than that obtained with standard NP elution mode (Rs= 10.67) (see Fig. 4) [45]. 
Ferretti et al. [50] studied column temperature influence on the chromatographic behavior of lansoprazole 
(LAN) using a Chiralpak IC and ethanol/water (50:50, v/v) as mobile phase. The retention and 
enantioselectivity factors were recorded at 25, 30, 35 and 40 ºC. The resolution factor incremented from 
2.63 to 3.05 within the temperature range, mainly due to an improvement in column efficiency. Besides, at 
40 ºC an appreciable reduction of the analysis time (from about 12 to 8 min) was observed. And an impurity 
(IMP-A) partially resolved was also studied in the same temperature range. The authors focused attention 
towards the isolation of enantiopure samples of both chiral compounds and their stereochemical 
assignment. The NP-HPLC resolutions were carried out with the same column. Mixtures of n-
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hexane/ethanol/diethylamine (60:40:0.1 and 40:60:0.1, v/v/v, respectively) were selected as the best mobile 
phases to provide enantioseparation of LAN and IMP-A, respectively. The results demonstrate that the 
resolution reached an optimum value when the column temperature was set at 35 ºC. 
 
5 Future Perspectives 
5.1. Liquid chromatography coupled to mass spectrometry 
 
Liquid chromatography–mass spectrometry (LC–MS) applications have grown significantly since 1980, 
primarily due to the introduction of the atmospheric pressure ionization (API) technique for the LC–MS 
interfaces, which overcomes the robustness and sensitivity issues of the earlier LC–MS interfacing ones. 
Enantiomeric LC–MS separation techniques combine the resolving power of HPLC and the sensitivity and 
specificity of mass spectrometric detection [152].  
In recent literature (2013-2017), we have not found polar or normal-phase mode applications of total chiral 
LC–MS separations using immobilized polysaccharide-based CSPs. However, polar organic and NP-LC-
MS applications have been found in not so recent literature [153]. The mobile phase incompatibility issue 
with normal-phase mode was overcome by using a make-up liquid. However, this post-column addition 
reduces enantioresolution; therefore, further work should be done for the optimization of chromatographic 
and mass spectrometric ionization conditions. 
All chiral applications were found in the LC reversed-phase mode using tandem mass spectrometry (LC-
MS/MS), which is attributed to its compatibility with API-based MS ionization techniques. Pharmaceutical 
[81,96,76,89,70], biomedical [61,54] and agrochemical [103,104,107,102,101] applications were the 
dominant separation fields, and to a lesser extent are other industries such as fragrances and food, and 
also environmental studies.  
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The promise of wider applications based on the polar organic mode of chiral LC–MS using different 
immobilized CSPs has not yet been realized. Although it possesses the advantages of compatibility with 
API sources and high-resolution efficiency in a short analysis time. The primary reason may be that 
scientists are less familiar with this hybrid mode of LC–MS techniques and because of the infrequent use of 
high-throughput sample preparations using pure organic-based liquid handling techniques. 
 
5.2. Miniaturization of chiral separations 
 
Downscaling chromatographic techniques from conventional to micro or nano-HPLC is considered a “green 
analysis approach”. Instrumental miniaturization results in smaller solvent consumption and reduced waste 
production compared to the full-size laboratory instruments [154]. Several studies [155–157] show the 
feasibilty of miniaturization from conventional HPLC to nano-LC, capillary-LC (CLC), capillary 
electrophoresis (CE) and capillary electrochromatography (CEC) for chiral separations with polysaccharide 
based-CSPs. An early study attempted the simulatenous enantioseparation of thalidomide and its 
hydroxylated metabolites using three different polysaccharide-type CSPs under conventional HPLC, CLC, 
and CE [155]. Baseline separation of the six peaks was achieved using conventional HPLC; however, for 
CLC and CE, this was not possible. Hence, column length had to be increased to provide the same 
baseline separation displayed by the conventional column. These results show that the performance of 
conventional size HLPC columns is not yet comparable to the miniaturized counterpart, mainly due to the 
lower CS content in them. Although several applications have been reported [158,159], further work is 
necessary in this field, e.g., new CSPs development, availability of commercial capillary columns and less 
expensive instrumentation. Finally, the use of chip technology seems to be very promising. Here dead 
volumes are minimized providing, in addition to short analysis time, high efficiency and resolution. 
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5.3. Chemometric analysis 
 
In enantiomeric purity determinations, the enantiomer of interest has to be usually quantitatively analyzed 
at levels below 1% (minority peak) of the main enantiomer. Higher accuracy in detection and quantitation of 
the minor signal close to the major peak can be obtained as larger the enantioresolution is. These large 
enantioresolution factors are not so easily achieved in chiral chromatography at a reasonably analysis time 
[160], and it is very often observed a partial overlapping between both enantiomer profiles, causing a loss 
in the quantitation accuracy. Chemometric analysis of multivariate chromatographic data for quantitative 
purposes is becoming popular, particularly for the study of complex samples [161–163]. The expressions 
‘chromametrics’ [164] and ‘chroMATHography’ [165] have been coined to describe the combination of 
chromatography and chemometrics/mathematics. Recently, it has been demonstrated how chiral liquid 
chromatography combined with multivariate techniques, specifically unfolded-partial least-squares 
regression (U-PLS), provides a powerful analytical methodology to face unresolved profiles [166–168].  
Chemometric methods coupled to chromatographic-spectroscopy data can be a powerful analytical 
strategy in the following circumstances: (1) to reduce analysis time by using stronger mobile phases to 
elute earlier all the interesting peaks and (2) to circumvent the usual lower enantioresolution factors 
achieved in reversed-phase chiral systems as compared to the larger normal phase enantioselectivities 
and, last but not least, to reduce analysis cost. 
 
6 Concluding remarks 
 
It is well known the extremely broad applicability showed by polysaccharide type CSPs in HPLC chiral 
analysis. One of the most remarkable recent advancement for this family constitutes the immobilization of 
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polysaccharide derivatives of cellulose and amylose onto a chromatographic support, allowing them to 
extend the choice of solvents used as mobile phases, even to “non-standard” solvents which are prohibited 
for the coated ones. Then immobilized CSPs have great versatility in method development, can be used to 
monitor certain stereospecific reactions carried out only in prohibited solvents, and enable preparative scale 
chromatography. Although they have many, it is important to know that the applications of immobilized 
CSPs are not yet fully explored and studies are still in progress.  
Moreover, these immobilized CSPs admit column downscaling and then the miniaturized techniques 
developed with them contribute to the current trends towards green chemistry. Still effort must be put in 
instrumental improvements and technological advances that allow coupling MS detection and extend 
applications of these CSPs used under normal or polar organic modes, respectively. Finally, the 
development of combined chemometric methods with spectroscopic-chromatographic data as a powerful 
analytical strategy for the analysis of strongly overlapped enantiomeric peak profiles is not yet exploited. 
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Figure Captions 
 
Figure 1. Distribution of enantiomeric excess determinations reported in Angew. Chem. Int. Ed. in 2012. 
The numbers in parentheses are the amount of papers published in each category. (A) for different 
separation techniques (B) for different types of CSPs used for HPLC and SFC. (C) for different chemical 
nature of polysaccharide-based CSPs. OD, AD, OJ and AS are coated-type and IA, IB, IC, ID and IE are 
immobilized-type CSPs. (Reproduced with permission of Elsevier from Ref. [14] © 2014 Elsevier). 
Figure 2. Number of publications reported in the last five years for chiral separations obtained with 
Chiralpak columns by Scopus database under (a) HPLC, and (b) SCF methods.  
Figure 3. HPLC chromatograms illustrating the enantioseparation obtained on the Chiralpak ID (left) and 
Chiralpak IF (right) columns for (a) albendazole sulfoxide (ABZ-SO) and (b) fenbendazole sulfoxide (FBZ-
SO). Mobile phase composition corresponding to polar organic (POLC), hydrophilic interactions (HILIC) and 
reversed phase (RPLC) liquid chromatography modes, are indicated in the Figure. UV detection at 254 nm; 
flow rate: 1 mL min−1; column temperature: 25 ºC. (Reproduced with permission of Elsevier from Ref. [57] © 
2014 Elsevier). 
Figure 4. HPLC chromatograms obtained at different temperatures under NP and RP liquid 
chromatography modes for lansoprazole (LAN) and an impurity (IMP-A). Left side (NP mode): Chiralpak IC 
column (250 mm x 4.6 mm I. D.). Mobile phase composition: n-hexane/ethanol/diethylamine (60:40:0.1, 
v/v/v) for LAN and n-hexane/ethanol/diethylamine (40:60:0.1, v/v/v) for IMP-A. Right side (RP mode): 
Chiralpak IC-3 column (100 mm x 4.6 mm). Mobile phase composition: ethanol/water (50:50, v/v). UV 
detection at 280 nm; flow rate, 1.0 mL/min; column temperature, from top to bottom: 40, 35, 30, and 25 ºC. 
(Reproduced with permission of Wiley and Sons from Ref. [50] © 2016 John Wiley & Sons).
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Table 1: Name of various polysaccharide-based commercial columns. 
Trade name Chemical name Trade name Chemical name 
Cellulose based CSPs Amylose based CSPs 
Chiralcel OBa) (c) 
Chiralcel OB-Ha) (c) 
Eurocel 02b) (c) 
Tribenzoate 
Chiralpak ADa) (c) 
Chiralpak AD-Ra) (c) 
Chiralpak AD-RHa) (c) 
Lux Amylose-1c) (c) 
CHIRAL ART Amylose-Cf) (c) 
Reprosil Chiral-AMi) (c) 
AmyCoatd) (c) 
RegisPacke) (c) 
tris-(3,5-dimethylphenylcarbamate) 
Chiralcel OJa) (c) 
Chiralcel OJ-Ra) (c) 
Lux Cellulose-3c) (c) 
Eurocel 03b) (c) 
CHIRAL ART Cellulose-SJf) (c) 
tris-(4-methylbenzoate) 
 
Chiralpak IAa) (i) 
Lux i-Amylose-1c) (i) 
CHIRAL ART Amylose-SAf) (i) 
 
Chiralpak ARa) (c) tris-[(R)-1-phenylethylcarbamate] 
Chiralcel CMBa) (c) tris-(3-methylbenzoate) 
Chiralpak ASa) (c) 
Chiralpak AS-Ha) (c) 
Chiralpak AS-RHa) (c) 
tris-[(S)-α-methylphenylcarbamate 
Chiralcel OCa) (c) 
Eurocel 04b) (c) 
Triphenylcarbamate 
Chiralpak AYa) (c) 
Chiralpak AY-Ha) (c) 
Chiralpak AY-RHa) (c) 
Lux Amylose-2c) (c) 
Sepapak-3g) (c) 
RegisPack CLA-1e) (c) 
tris-(5-chloro-2-methylphenylcarbamate) 
Chiralcel ODa) (c) 
Chiralcel OD-Ha) (c) 
Chiralcel OD-Ra) (c) 
Chiralcel OD-RHa) (c) 
Lux Cellulose-1c) (c) 
Eurocel 01b) (c) 
CHIRAL ART Cellulose-Cf) (c) 
Sepapak-1g) (c) 
Astec Cellulose DMP h) (c) 
Reprosil Chiral-OM i) (c) 
CelluCoatd) (c) 
RegisCelle) (c) 
tris-(3,5-dimethylphenylcarbamate) 
Chiralpak IBa) (i) 
CHIRAL ART Cellulose-SBf) (i) 
Chiralpak AZa) (c) 
Chiralpak AZ-Ha) (c) 
Chiralpak AZ-RHa) (c) tris-(3-chloro-4-methylphenylcarbamate) 
Chiralcel OFa) (c) tris-(4-chlorophenylcarbamate) 
 
Chiralpak IFa) (i) 
 
Chiralcel OGa) (c) tris-(4-methylphenylcarbamate) Chiralpak IDa) (i) tris-(3-chlorophenylcarbamate) 
Chiralcel OAa) (c) triacetate on silica gel Chiralpak IEa) (i) tris-(3,5-dichlorophenylcarbamate) 
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Chiralcel CTAa) (c) triacetate microcrystalline Chiralpak IGa) (i) tris-(3-chloro-5-methylphenylcarbamate) 
Chiralcel OKa) (c) Tricinnamate 
 
Chiralcel OXa) (c) 
Chiralcel OX-Ha) (c) 
Chiralcel OX-RHa) (c) 
Lux Cellulose-4c) (c) 
Sepapak-4g) (c) 
tris-(4-chloro-3-methylphenylcarbamate) 
Chiralcel OZa) (c) 
Chiralcel OZ-Ha) (c) 
Chiralcel OZ-RHa) (c) 
Lux Cellulose-2c) (c) 
Sepapak-2g) (c) 
tris-(3-chloro-4-methylphenylcarbamate) 
Sepapak-5g) (c) 
tris-(3,5-dichlorophenylcarbamate) 
 
Chiralpak ICa) (i) 
Lux i-Cellulose-5c) (i) 
CHIRAL ART Cellulose-SCf) (i) 
 
a) Supplier: Daicel Chemical Industries; b) Knauer; c) Phenomenex; d) Kromasil; e) Regis Technologies Inc.; f) YMC Europe GMBH; g) Sepaserve; h) Sigma-Aldrich; i) Dr. Maisch 
GmbH. (i): Immobilized polysaccharide-based CSPs, (c): Coated polysaccharide-based CSPs.
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Table 2: Chiral resolution of different pharmaceutical, biological and veterinary compounds on immobilized polysaccharide-based. 
Compound (Sample) Chromatographic conditions Chiralpak column Chromatographic parameters Ref. 
BMT-094817 (Human 
plasma) 
0.1% HFor/ACN:IPA (50:50) (55:45), 1mL/min, 
50°C, LC-MS/MS 
IA-3 1504.6mm, 3µm (A) Rs=1.90, α=1.50 [52]  
6-substituted carbamoyl 
benzimidazoles (Standard 
stock solution) 
(a)MTBE/MeOH/HFor, (b)MTBE/EtOH/HFor, 
(c)MTBE/PrOH/HFor, (d)MTBE/IPA/HFor, 
(e)MTBE/BuOH/HFor, (f)MTBE/t-BuOH/HFor, 
alcohol (1.37M) in MTBE with 0.1% HFor, 
1mL/min, 25°C, 271 and 286nm 
IA and IC 2504.6mm, 5µm (A) 
IA (a)Rs3.26, α1.24; (b)Rs3.40, α1.56; 
(c)Rs2.38, α1.20; (d)Rs=0.00, α=1.00; 
(e)Rs2.38, α1.47; (f)Rs1.95, α1.18 
IC (a)Rs7.08, α2.25; (b)Rs7.90, α2.42; 
(c)Rs6.42, α2.41; (d)Rs6.89, α2.63; 
(e)Rs6.65, α2.72; (f)Rs5.03, α2.59 
[53] 
Phosphatidylcholine 
hydroperoxide with 13S-
hydroperoxy-9Z,11E-
octadecadienoic acid (Soy 
lecithin) 
MeOH/NH4Ac 5mM (80:20), 1.0mL/min, 40°C, 
LC-MS/MS 
IA, IB, IC, ID, IE and IF 
2504.6mm, 5µm (A) 
IA Rs=1.9, IB Rs=2.2, IC Rs=0.0, 
ID Rs=3.6, IE Rs=nd, IF Rs=0.0 
[54] 
Bicalutamide and impurities 
(Standard stock solution) 
(a)n-Hex/EtOH (70:30), (b)n-Hex/IPA (65:35), 
(c)n-Hex/EA/EtOH (100:30:5), 1mL/min, 25 °C, 
280nm 
IA 2504.6mm, 5µm (A) 
IA 25010mm, 5µm (S) 
(a)Rs=3.12-13.79, α=1.57-3.56 
(b)Rs=3.00-9.07, α=1.74-2.71 
(c)Rs=1.83-9.96, α=1.28-2.15 
[45] 
Nadolol (Standard stock 
solution) 
(a)IPA/ACN with 0.1% DEA (10:90), (b)EtOH/n-
Hex/DEA (20:80:0.1), (c)EtOH/n-Hep/DEA 
(20:80:0.1), 1mL/min, 23°C 
IA 2504.6mm, 5µm (A), 
home-packed with 20 μm (P) 
(a)Rs2,1=3.95, Rs3,2=2.89, Rs4,3=9.18 
(b)Rs2,1=1.72, Rs3,2=2.91, Rs4,3=4.03 
(c)Rs2,1=2,74, Rs3,2=2.88, Rs4,3=5,19 
[51] 
Darunavir (Dried blood spot) 
n-Hex/EtOH/DEA (75:25:0.1), 1mL/min, 20°C, 
266nm 
IA 2504.6mm, 5µm (A) Rs>1.5 [55] 
5-bromo-3-ethyl-3-(4- 
nitrophenyl)-piperidine-2,6-
dione (Standard stock 
100%ACN, 1mL/min, 27 °C, 254nm IA 2504.6mm, 5µm (A) 
Rs1=3.88, α1=1.22 
Rs2=7.04, α2=1.69 
Rs3=8.22, α3=1.49 
[56] 
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solution) 
Profens (Standard stock 
solution) 
(a)HFor (pH=2.10)/ACN (60:40), (b) HFor 
(pH=2.10)/ACN (70:30), 1mL/min, 25°C, 220-
264nm 
IA 2504.6mm, 5µm (A) 
(a)Rs4.75, α1.22 
(b)Rs4.36, α1.23 
[38] 
Albendazole and 
fenbendazole sulfoxides 
(ABZ-SO and FBZ-SO) 
(Synthetic compounds) 
(a)100%ACN, (b)100%MeOH, (c) EtOH/w 
(100/5), (d) ACN/w (100:10), (e) ACN/w 
(100:20), (f) ACN/w (100:5), 1.0mL/min, 25 °C, 
254nm 
IA-3, ID-3, IE-3 and IF-3 
1004.6mm, 3µm (A) 
IF-3 (a)αABZ-SO=3.89, αFBZ-SO=4.04 
ID-3 (a)αABZ-SO=3.56, (b)αFBZ-SO=3.29 
IE-3 (c)Rs=5.06, αFBZ-SO=1.99 
IA-3 (c)Rs=3.65, αABZ-SO=2.16 
ID-3 (d)Rs=6.95, αABZ-SO=3.34 
IF-3 (e)Rs=5.74, αABZ-SO=3.35 
ID-3 (f)Rs=6.28, αFBZ-SO=3.35 
IF-3 (d)Rs=6.83, αFBZ-SO=4.77 
[57] 
Steroisomers and 
geometrical isomers of 
pitavastatin (Drugs) 
n-Hep/BuOH/MeOH/HFor/DEA 
(94:3.5:2.5:0.2:0.1), 
1.0mL/min, 35°C, 250nm 
IA 2504.6mm, 5µm (A) Rs~1.5 [58] 
Naftopidil and o-desmethyl 
metabolites (Rat feces) 
MeOH/ACN/acetate buffer (pH=5.3, 5mM) 
(3:33:22), 0.5mL/min, 25°C λex=290nm and 
λem=340nm 
IA 2504.6mm, 5µm (A) Rs~1.5 [59] 
Carvedilol (Human urine) 
MeOH/EtOH/w/DEA (64:15:12:0.3), 1.5mL/min, 
35°C, 240nm 
IA-3 1004.6mm, 3µm (A) Rs=9.27, α=2.78 [60] 
OTX015 (Mice plasma) 
0.2% ammonia/ACN (20:80), 1.2mL/min, 40°C, 
LC-MS/MS 
IA 2504.6mm, 5µm (A) Rs=4.86 [61] 
OTX015 (Bulk drug) MeOH/DEA (100:0.1), 1mL/min, 35°C, 254nm IA 2504.6mm, 5µm (A) Rs=3.74, α=1.76 [62] 
Pidotimod (Standard stock 
solution) 
MTBE/ACN/TFA (35:65:0.2), 1.0mL/min, 25°C, 
λ=210nm 
IA 2504.6mm, 5µm (A) Rs=3.8, α=1.57 [63] 
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Purine Derivatives (Standard 
stock solution) 
n-Hex/IPA (90:10), 1.0mL/min, 35°C, 254nm IB 2504.6mm, 5µm (A) Rs=0.0-1.99, α=1.03-1.09 [64] 
Bevantolol (Standard stock 
solution) 
ACN/buffer KH2PO4 20mM, pH=4.5 (25:75), 
0.8 mL/min, 25°C, 259nm 
IB 2504.6mm, 5µm (A) Rs=3.90, α=1.26 [65] 
Propranolol (Rat Serum) 
n-Hex/EtOH/TEA (95:5:0.4), 0.6mL/min, 
λex=290nm and λem=375nm 
IB 2504.6mm (A) Rs=3.37, α=1.24 [66] 
β-receptor blockers 
(Standard stock solution) 
(a)n-Hex/IPA/DEA (70:30:0.5), (b)n-
Hex/EtOH/DEA (70:30:0.5), (c)n-Hex/PrOH/DEA 
(70:30:0.5), 1.0mL/min, 30°C, 275nm 
IB 150 4.6mm (A) 
(a)Rs3.80, α5.51 
(b)Rs4.54, α3.78 
(c)Rs=0.74-5.95, α5.55 
[67] 
β-receptor blockers (Bulk 
drug) 
n-Hex/EtOH/DEA (70:30:0.5), 0.8mL/min, 20°C, 
295, 274, 224 and 223nm 
IB 250 4.6mm, 5µm (A) Rs=3.07-12.2, α=1.2-2.4 [68] 
Acenocoumarol (Tablets 
formulations) 
n-Hex/EtOH (70:30), 0.5mL/min, 25°C, 383nm IB 250 4.6mm, 10µm (A) 
Rs1=0.81, α1=1.051 
Rs2=1.38, α2=1.109 
Rs3=1.08, α3=1.100 
Rs4=1.1, α4=1.131 
[69] 
Miconazole (Rat plasma) 
ACN/buffer NH4HCO3 5mM (80:20), 
0.6 mL/min, 20°C, LC-MS/MS 
IC 2504.6mm, 5µm (A) Rs>1.5 [70] 
α-Hydroxyallylphosphonates 
and Phosphonoallylic 
Carbonate Derivatives 
(Synthetic compounds) 
n-Hex/IPA (90:10), 1.0mL/min, 25°C, 210nm IC-3 1004.6mm, 3µm (A) Rs5.9, α=1.04-1.63 [71] 
Dihydropyridines (Standard 
stock solution) 
(a)n-Hex/IPA (85:15), (b)n-Hex/IPA (92:8), (c)n-
Hex/IPA/EtOH (97:2:1), 1.0mL/min, 25°C, 
230nm 
IC 2504.6mm, 5µm (A) 
(a)Rs=5.65-5.80, α=1.47-1.48 
(b)Rs=1.76-1.92, α=1.15-1.18 
(c)Rs=1.47-1.84, α=1.14-1.15 
[72] 
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Proton pump inhibitors 
(Standard stock solution) 
(a)n-Hex/EtOH/DEA (50:50:0.1), (b)n-
Hex/EtOH/DEA/TFA (50:50:0.1:0.1), 
1.0mL/min, 30 °C, 280 and 300nm 
IC 2504.6mm, 5µm (A) 
(a)Rs=4.91-10.15, α=1.51-1.99 
(b)Rs=5.0-10.2, α=1.46-1.98 
[73] 
Lansoprazole and impurities 
(Standard stock solution) 
(a)n-Hex/EtOH/DEA (60:40:0.1), (b)EtOH/w 
(50/50),1.0mL/min, 25°C, 280nm 
IC 2504.6mm, 5µm (A) 
IC-3 250 4.6mm, 3µm (A) 
IC 25010mm, 5µm (S) 
IC (a)Rs=5.36-5.67, α=1.79-2.00 
IC-3 (b)Rs=1.18-2.63, α=1.26-1.50 
[50] 
Antihistamines (Standard 
stock solution) 
(a)n-Hex/IPA/DEA (95:5:0.1), (b)n-
Hex/EtOH/DEA (95:5:0.1), 0.8mL/min, 25°C, 
227 and 262nm 
IC 2504.6mm, 5µm (A) 
(a)Rs5.75, α=1.05-1.36 
(b)Rs=0.63-2.82, α=1.04-1.15 
[74] 
Ezetimibe optical isomers 
(Bulk drug) 
n-Hex/IPA/DEA (90:10:0.1), 1.0mL/min, 25°C, 
256nm 
IC 250 4.6mm, 5µm (A) 
Rs1,2=3.02, α1,2=1.37 
Rs2,3=2.15, α2,3=1.25 
Rs3,4=2.20, α3,4=1.23 
[75] 
Proton pump inhibitors 
(Wastewater and river water) 
ACN/ 5mM NH4Ac (60:40), 0.6mL/min, 15°C, 
LC-MS/MS 
IC 250 4.6mm, 5µm (A) Rs>1.5 [76] 
10-hydroxycamptothecin 
(Synthetic compounds) 
n-Hex/EtOH (50:50), 1.0mL/min, 40°C, 270nm IC 250 4.6mm, 5µm (A) Rs=3.2 [77] 
3-(S)-Quinuclidinol 
(Synthetic compounds) 
n-Hex/EtOH/IPA/DEA (80:8:12:0.4), 0.8mL/min, 
15°C, 230nm 
IC 250 4.6mm, 5µm (A) Rs=11.4, α=2.18 [78] 
Rabeprazole and impurities 
(Pharmaceutical 
formulations) 
Gradient programme: (A)phosphate buffer at 
pH=7.0, (B)ACN, t(min)/B (v/v): 0.0/35, 20.0/70, 
25.0/35, 30.0/35, 35°C, 1.0mL/min, 282nm 
IC 2504.6mm, 5µm (A) 
Rs=15.35 (Imp-B), 9.45 (S-Rab), 3.95 (R-
Rab), 13.89 (Imp-A) 
[79] 
Xeljanz (Active 
pharmaceutical ingredients 
and tablets) 
n-Hex/EtOH/DEA (65:35:0.1), 0.9mL/min, 40°C, 
289nm 
IC 2504.6mm, 10µm (A) Rs=2.07 [80] 
Lansoprazole (Human 
plasma) 
10mM NH4Ac with 0.05% HAc/ACN (50:50), 
0.6mL/min, 30°C, LC-MS/MS 
IC 1504.6mm, 5µm (A) Rs~1.5 [81] 
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Carboxilate ester of 
evacetrapib (Standard stock 
solution) 
n-Hex/MTBE/IPA (90:9:1), 1.0mL/min, 40°C, 
260nm 
IC-3 250 4.6mm, 3µm (A) 
Rs=1.96 (between the trans-R-enantiomers 
and the penultimate) 
[82] 
Oxaliplatin (Standard stock 
solution) 
(a)ACN/w (100:5), 40°C, (b)MEOH/w (100:5), 
(c) EtOH, 1.0mL/min, 25°C, 210nm 
IC-3 1004.6mm, 3µm (A) 
(a)Rs=5.79, α=2.03, (b)α=1.81 
(c)Rs=1.81, α=2.04 
[44] 
Pioglitazone (Rat plasma) n-Hex/IPA (70:30), 1.0mL/min, 35°C, 225nm IC 2504.6mm, 5µm (A) Rs=3.43 [83] 
Darunavir (Standard stock 
solution) 
(a)n-Hex/IPA/DEA (65:35:0.1), (b)n-Hex/EtOH 
(65:35:0.1), (c)n-Hex/1-PrOH (65:35:0.1), 
1.2mL/min, 25°C, 266nm 
IC 250 4.6mm (A) 
(a)Rs=6.96, α=2.20 
(b)Rs=3.48, α=1.50 
(c)Rs=5.13, α=1.98 
[84] 
Indapamide (Rat whole 
blood) 
n-Hex/IPA (70:30), 0.8mL/min, 25°C, 240nm IC 2504.6mm, 5µm (A) Rs<2 [85] 
Nipecotic acid (Synthetic 
compounds) 
20mM HFor and 20mM N,N-
diisopropyleethylamine in ACN, 1.0mL/min, 
40°C, 490nm 
ID-3 250 4.6mm, 3µm (A) Rs=5.44 [86] 
Declatasvir and its 
enantiomers (Standard stock 
solution) 
Gradient programme: (A) MeOH/DEA (100/0.1), 
(B) ACN/DEA (100/0.1), t(min)/B (v/v): 
0.0/10,10.0/80, 15.0/80, 15.1/10, 25.0/10, 40°C, 
1.0mL/min, 315nm 
ID-3 2504.6mm, 3µm (A) 
Rs1,2=4.52, α1,2=1.27 
Rs2,3=2.56, α2,3=1.11 
Rs3,4=6.21, α3,4=1.34 
[87] 
Omeprazole and impurities 
(Standard stock solution) 
ACN/w (50:50), 1.0 mL/min, 40°C, 280nm ID-3 1004.6mm, 3µm (A) 
Rs>1.5 
α=3.11; α=2.56; α=1.10 
[88] 
Efonidipine (Human plasma) ACN/w (60:40), 0.4mL/min, 25°C, LC-MS/MS ID 2504.6mm, 5µm (A) Rs=3.02, α=1.13 [89] 
Oxiracetam (Beagle dog and 
rat plasma) 
n-Hex/EtOH/TFA (78:22:0.1), 1.0mL/min, 35°C, 
214nm 
ID 250 4.6mm, 5µm (A) Rs>>1.5 [90,91] 
Several pharmaceutical 
compounds (Standard stock 
solution) 
n-Hex/IPA (90:10), 1.0mL/min, 25°C, 219 and 
270nm 
ID 2504.6mm, 5µm (A) 
ID-3 1503mm, 3µm (A) 
ID Rs=1.33-7.71, α=1.24-4.69 
ID-3 Rs=2.25-3.85, α=2.70-3.34 
[92] 
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Triazole drugs and 
diastereomeric mixture 
(Standard stock solution) 
n-Hex/IPA/EtOH/DEA (60:35:5:0.1), 
1.0mL/min, 25°C, 230nm 
ID 250 4.6mm, 5µm (A) 
Rs1,2=-, α1=7.67 
Rs2,3=2.12, α2=8.65 
Rs3,4=6.27, α3=12.03 
Rs3,4=8.16, α4=18.25 
[93] 
Proton pump inhibitors 
(Standard stock solution) 
(a)100%MeOH, (b)100%EtOH, (c)100%THF, 
(d)100%ACN, 1.0mL/min, 25°C, 280nm 
ID-3 100 4.6mm, 3µm (A) 
IE-3 100 4.6mm, 3µm (A) 
ID-3 (a)α2.94, (b)α1.59, (c)α=1.00, 
(d)α=1.18-3.15 
IE-3 (a)α1.24, (b)α1.40, (c)α=1.00, (d) 
α=1.18-1.62 
[94] 
Besifloxacin (Bulk drug and 
formulations) 
DCM/IPA/TFA/DEA (90:10:0.3:0.5), 1.5mL/min, 
15°C 
IE-3 2504.6mm, 3µm (A) Rs=2.07, α=2.14 [95] 
Pantoprazole (Human 
plasma) 
10mM NH4AcACN with 0.1% HAc/ACN (28:72), 
0.5mL/min, 30°C, LC-MS/MS 
IE 1504.6mm, 3µm (A) Rs>1.5 [96] 
Triclabendazole (Synthetic 
compound) 
(a)n-Hex/EtOH/EA/TFA (70:1:30:0.1), (b)n-
Hex/IPA/TFA (70:30:0.1), (c)n-Hex/EtOH/TFA 
(70:30:0.1), (d) ACN/w (100:100), 1.0mL/min, 
25°C, 294nm 
IF-3 2504.6mm, 3µm (A) and 
(S) 
(a)Rs=5.17, α=1.45 
(b)Rs=1.54, α=1.20 
(c)Rs=2.67, α=1.26 
(d)Rs=1.99 
[41] 
Ricobendazole (Synthetic 
compound) 
n-Hex/IPA/EtOH/DEA (60:35:5:0.1), 
1.0mL/min, 25°C, 230nm 
IG-3 2504.6mm, 3µm (A) 
IG 25010mm (S) 
(a)Rs=10.90; α=2.35, 
(b)Rs=14.25; α=2.41 
[40] 
(A)=analytical, (S)=semipreparative, (P)=preparative, MeOH=methanol, EtOH=ethanol, IPA=2-propanol, PrOH=1-propanol, BuOH=1-butanol, t-BuOH=tert-butanol, ACN=acetonitrile, 
THF=tetrahydrofuran, w=water, DEA=diethylamine, TEA=triethylamine, HFor=Formic acid, TFA=Trifluoroacetic acid, n-Hex=n-hexane, n-Hep=n-heptane, EA=ethyl acetate, DCM=dichloromethane, 
MTBE=methyl tert-butyl ether, nd=no detected. 
 
 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Table 3: Chiral resolution of different pesticides on immobilized polysaccharide-based CSPs. 
Compound (Sample) Chromatographic conditions Chiralpak column Chromatographic parameters Ref. 
Pyriproxyfen and metabolites 
(Standard stock solution) 
(a)n-Hex/EtOH (95:5), (b)ACN/water (50:50), 
0.3-0.8mL/min, 15°C, 220, 230 and 270nm 
IA, IB and IC 2504.6mm, 5µm 
(A) 
IA (a)Rs=2.39-5.64, α=1.11-1.45 
IB (b)Rs=3.31, α=1.08 
[97] 
Dufulin (α-
aminophosphonate) (Soil) 
n-Hex/EtOH (90:10), 1.0mL/min, 25°C IA 2504.6mm, 5µm (A) Rs>1.5 [98] 
Indoxacarb (Natural waters) n-Hex/IPA (70:30), 1.0mL/min, 30 °C, 310nm 
IA 2504.6mm, 5µm (A) 
IA 250 10mm, 5µm (S) 
Rs>1.5 [48] 
Vinclozolin (Soil) 
(a)n-Hex/IPA (98:2), (b)n-Hex/IPA (95:5), (c)n-
Hex/EtOH (98:2), (d) n-Hex/BuOH (95:5), 
0.8mL/min, 20°C, 220nm 
IB 2504.6mm, 5µm (A) 
(a)Rs=2.90, α=1.15 
(b)Rs=2.51, α=1.14 
(c)Rs=2.67, α=1.16 
(d)Rs=2.56, α=1.13 
[99] 
Phenylpyrazole pesticides 
and metabolites (Standard 
stock solution) 
(a) n-Hex/IPA (95:5), (b) n-Hex/EtOH (95:5), (c) 
PE/IPA (98:2), (d) PE/EtOH (95:5), 1.0mL/min, 
30°C, 230nm 
IB 2504.6mm, 5µm (A) 
(a)Rs=1.62-2.30, α=1.25-1.26 
(b)Rs=1.67-3.40, α=1.18-1.38 
(c)Rs=1.56-16.82, α=1.22-6.71 
(d)Rs=1.67-9.40, α=1.22-2.61 
[100] 
Benalaxyl and benalaxyl acid 
(Soil) 
ACN/w/HFor (90:10:0.1), 0.5mL/min, 20°C, LC-
MS/MS 
IC 2504.6mm (A) Rs~1.5 [101] 
Furalaxyl (Residues in 
Tenebrio molitor larvae and 
wheat bran) 
ACN/w (80:20), 0.4mL/min, 20°C, LC-MS/MS IC (A) Rs~1.5 [102] 
Fenoxaprop-ethyl and its 
metabolites (Soil with 
earthworms) 
MeOH/w/HFor (75:25:0.1), 0.5 mL/min, 20°C, 
LC-MS/MS 
IC 2504.6mm (A) Rs~1.5 [103] 
Fluazifop (flu) and fluazifop- (a)MeOH/ 0.1% aqueous HFor (80:20), IC 2504.6mm, 5µm (A) (a)Rs=1.57, α=1.24 (flu-butyl) [104] 
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butyl (flu-butyl) (Water and 
soil) 
(b)MeOH/ 0.1% aqueous HFor (68:32), 
0.5mL/min, 25°C, LC-MS/MS 
(b)Rs=1.87, α=1.18 (flu) 
Fenpropathrin (Soil) 
(a)MeOH/w (1000:0 to 70:30), (b)ACN/w (65:35 
to 50:50), 0.8mL/min, 230nm 
IC 2504.6mm, 5µm (A) 
(a)Rs=-, α=1.00 
(b)Rs=0.34-0.64, α=1.03-1.03 
[105] 
Tanikolide and intermediates 
(Standard stock solution) 
(a)n-Hex/IPA (90:10), (b)n-Hex/EtOH (95:5), 
0.8mL/min, 25°C, 206 and 230nm 
IC 2504.6mm, 5µm (A) 
(a)Rs=1.47-8.24, α=1.21-1.62 
(b)Rs=1.03-2.54, α=1.09-1.13 
[106] 
Indoxacarb (Green tea) ACN/w (60:40), 0.8mL/min, 30°C, LC-MS/MS IC 2504.6mm, 5µm (A) Rs~1.5 [107] 
Diclofop-methyl and diclofop 
(Loach liver microsomes in 
vitro) 
n-Hex/IPA/TFA (96:4:0.1), 1.0mL/min, 20°C, 
260nm 
IC 2504.6mm (A) Rs>1.5 [108] 
Triazole fungicides 
(Groundwater and river 
water) 
(a)PE/EtOH (95:5), (b)n-Hex/IPA (95:5), 
1.0mL/min, 20°C, 220 and 230nm 
IC 2504.6mm (A) 
(a)Rs=1.36-9.14, α=1.10-1.51 
(b)Rs=1.38-8.42, α=1.12-1.46 
[109] 
Napropamide (Tomato, 
cucumber, rape, cabbage, 
and soil) 
n-Hex/IPA (85:15), 1.0mL/min, 35°C, 225nm IC 2504.6mm (A) Rs=11.75, α=1.11 [110] 
(A)=analytical, (S)=semipreparative, MeOH=methanol, EtOH=ethanol, IPA=2-propanol, BuOH=1-butanol, ACN=acetonitrile, w=water, HFor=Formic acid, TFA=Trifluoroacetic acid, n-Hex=n-hexane, 
PE=petroleum ether. 
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Table 4: Chiral resolution of organic, polyaromatic, natural and synthetic compounds on immobilized polysaccharide-based CSPs. 
Compound Chromatographic conditions Chiralpak column Chromatographic parameters Ref. 
Chiral Sulfoxides (Standard 
stock solution) 
(a)n-Hep/IPA/DEA (90:10:0.1), (b)n-
Hep/EtOH/DEA (90:10:0.1) 1mL/min, 20°C, 254 
and 230nm 
IA 2504.6mm, 5µm (A) 
(a)Rs1.88, α1.14 
(b)Rs5.91, α1.49 
[111] 
Underivatized chiral primary 
amines (Standard stock 
solution) 
(a)ACN/IPA/BA (97:3:0.1), (b)n-Hep/EtOH/BA 
(90:10:0.1), 2.0mL/min, 25°C, 280nm 
IA, IB, IC, ID, IF 2504.6mm, 
5µm (A) 
IA (a) α=1.54-4.33; (b)α=1.44-2.64 
IB (a)α=1.83; (b)α=1.59 
IC (a)α=1.47; (b)α=1.17-3.26 
ID (a)α=1.76-2.81; (b)α=1.23-2.53 
IF (a)α=2.58-3.11; (b)α=1.38 
[112] 
Cationic hetero[6]helicenes 
(Synthetic compounds) 
(a)MeOH/30mM KPF6 (90:10), (b)ACN/ 30mM 
NH4Ac (90:10), 1mL/min, 25°C, 420, 370 and 
450nm 
IA 2504.6mm, 5µm (A) 
ID 225 cm 25020mm; 5 μm (P) 
(S) 
(a)α=1.11-1.14, (b)α=1.08 [46] 
β-aminoketones (Synthetic 
compounds) 
(a)n-Hex/EtOH (95:5), (b)IPA, 
0.2-0.5mL/min, 25°C, 250, 260, 275 and 301nm 
IA and IB 1504.6mm, 5µm (A) 
IA (a)Rs1.89, α1.11 
IB (a)Rs=0.92-1.67, α=1.06-1.07 
(b)Rs0.62, α1.11 
[113] 
Chiral 9,9 Spirobifluorenes 
derivatives (Synthetic 
compounds) 
(a)CHCl3/IPA (95:5), 300nm (b)CHCl3/IPA 
(90:10), 325nm, 0.5mL/min 
IA 2504.6mm, 5µm (A) 
IA 25010mm, 5µm (S) 
Rs>>1.5, α=4.3 [47] 
3,5-disubstituted hydantoins 
(Synthetic compounds) 
(a)n-Hex/EtOH (80:20), (b)n-Hex/PrOH (80:20), 
(c)n-Hex/IPA (80:20), (d)n-Hex/BuOH (80:20), 
(e)n-Hex/t-BuOH (80:20), 0.5mL/min, 25°C, 
220nm 
IA 2504.6mm, 5µm (A) 
(a)α=1.33-2.21, (b)α=1.13-2.97 
(c)α1.71, (d)α=1.62-2.16 
(e)α=1.08-1.55 
[114] 
N-protected amino acids 
(Standard stock solution) 
n-Hex/EtOH/TFA (75:25:0.5), 
1.0 mL/min, 30°C, 310nm 
IA 2504.6mm (A) Rs=1.16-1.76, α=1.10-1.22 [115] 
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Polyhalogenated 4,4’-
bipyridines (Synthetic 
compounds) 
(a)n-Hex/IPA (90:10), (b)MeOH, (c)MeOH/IPA 
(50:50), (d)EtOH, (e)ACN, (f)n-Hep/THF (95:5), 
(g)n-Hep/THF/DCM (90:5:5), (h)n-
Hex/IPA/MeOH (90:5:5), 0.4-0.8mL/min, 22°C, 
220, 254, 280 and 360nm 
IA and IC 2504.6mm, 5µm (A) 
IC (a)Rs3.4, α1.34; (b)Rs=1.0-4.2, α=1.12-
1.51; (c)Rs=1.8-4.6, α=1.27-1.71; (d)Rs=2.5-
4.5, α=1.51-1.70; (e)Rs=3.7-5.9; α=1.54-
1.97; (f)Rs=0.7-4.9, α=1.06-1.59; (g)Rs=0.6-
3.6, α=1.04-1.53 
IA (h)Rs=0.7-4.2, α=1.12-1.47 
[116] 
Aliphatic amines as 
nitrobenzoxadiazole 
derivatives (Synthetic 
compounds) 
n-Hex/IPA (95:5), 1.0mL/min, 25°C, λex=470nm 
and λem=530nm 
IA, IB, IC, ID, IE and IF 
2504.6mm, 5µm (A) 
IA Rs6.06, α1.44,  
IB Rs1.0, α1.04,  
IC Rs8.73, α1.63,  
ID Rs=1.31-4.30, α=1.11-1.40,  
IE Rs10.89, α4.44,  
IF Rs=1.03-1.29, α=1.22-2.61 
[39] 
Atropisomeric 3,3’,5,5’-
tetrasubstituted-4,4’-
bipyiridines (Synthetic 
compounds) 
(a)n-Hex/IPA (90:10), (b)EtOH, (c)EtOH/IPA 
(80:20), 
0.4-0.8mL/min, 22°C, 220, 254, 280 and 360nm 
IA and IC 2504.6mm, 5µm (A) 
IA (a)Rs10.0, α2.59, (b)Rs3.6, α=1.06-
1.65, (c)Rs=0.6-5.4, α=1.07-1.60 
IC (a)Rs30.6, α8.33, (b)Rs7.4, α2.08 
[117] 
Troger´s Base derivatives 
(Synthetic compounds) 
(a)n-Hex/DCM (75:25), 1.5mL/min, (b)n-
Hex/DCM (80:20), 1.5mL/min 
IA 2504.6mm, 5µm (A) 
IA 25010mm, 5µm (S) 
(a)Rs=5.58, α=1.55 (rac-9) 
(b)Rs=5.65, α=1.30 (rac-12) 
[118] 
Polyarsenic derivatives 
(Synthetic compounds) 
DCM/n-Hex (2:8), 1.0mL/min, λ=254nm IA 2504.6mm, 5µm (A) Rs>>1.5 [119] 
Racemic 4,12-
difunctionalized 
[2,2]paracyclophanes 
(Synthetic compounds) 
n-Hex/EtOH (75:25), 1.0mL/min 
IC 2504.6mm, 5µm (A) 
IC 25010mm, 5µm (S) 
Rs>>1.5 [49] 
γ-substituted butanolide 
(Synthetic compounds) 
(a)n-Hex/IPA (70:30), (b)n-Hex/EtOH (70:30), 
0.8mL/min, 25°C, 254nm 
IC 2504.6mm, 5µm (A) 
(a)Rs=2.11-4.77, α=1.10-1.21 
(a)Rs=0.86-2.75, α=1.03-1.11 
[120] 
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Homoharringtonine and 
Intermediates (Synthetic 
compounds) 
(a)n-Hex/EtOH (90:10), (b)n-Hex/IPA 
(90:10),0.8mL/min, 25°C, 220nm 
IC 2504.6mm, 5µm (A) 
(a)Rs13.71, α1.73 
(b)Rs13.05, α1.81 
[121] 
Tris-(3-indolyl)-phosphane 
oxides (Standard stock 
solution) 
(a)DCM/IPA/DEA (100:15:0.1), -15°C, 
(b)DCM/IPA/DEA (100:10:0.1), -10°C, 
(c)DCM/IPA/DEA (100:1:0.1), 20°C, 
(d)ACN/w/DEA (100:100:0.1), -5°C, 1.0mL/min, 
280nm 
(I) IC 2504.6mm (A) 
(II) IC 1504.6 mm (A) 
(I) (a)Rs=2.70, α=1.67 
(I) (b)Rs=2.42, α=1.63 
(I) (c)Rs=2.65, α=1.33 
(II) (d)Rs~1.5 
[122] 
Farnesyl phenolic 
compounds (Extract of 
Genoderma sinense) 
n-Hex/IPA (65:35) IE (A) Rs~1.5 [123] 
(A)=analytical, (S)=semipreparative, (P)=preparative, MeOH=methanol, EtOH=ethanol, IPA=2-propanol, BuOH=1-butanol, t-BuOH=tert-butanol, ACN=acetonitrile, THF=tetrahydrofuran, w=water, 
DEA=diethylamine, BA=butyl amine, TFA=Trifluoroacetic acid, n-Hex=n-hexane, n-Hep=n-heptane, DCM=dichloromethane. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Highlights 
- Polysaccharide (amylose and cellulose) based CSPs are widely reviewed. 
- Fundamental aspects of their enantiorecognition ability in HPLC are discussed. 
- Comparison between coated and immobilized CSPs are done. 
- Advantages and applications of immobilized ones are described. 
- Perspective and future trends are summarized. 
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